CACOPARDO, Bruno Santi
 Distribuzione geografica
Continente #
NA - Nord America 13.108
AS - Asia 6.960
EU - Europa 6.670
SA - Sud America 1.254
AF - Africa 792
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 10
Totale 28.804
Nazione #
US - Stati Uniti d'America 12.705
SG - Singapore 3.537
RU - Federazione Russa 2.022
CN - Cina 1.846
IT - Italia 1.355
BR - Brasile 1.065
IE - Irlanda 982
UA - Ucraina 784
VN - Vietnam 615
CI - Costa d'Avorio 391
DE - Germania 347
FR - Francia 335
CA - Canada 308
IN - India 220
KR - Corea 211
FI - Finlandia 195
NG - Nigeria 179
SE - Svezia 165
GB - Regno Unito 150
SN - Senegal 87
BD - Bangladesh 69
AR - Argentina 67
NL - Olanda 65
PL - Polonia 62
HK - Hong Kong 58
MX - Messico 55
ID - Indonesia 46
JP - Giappone 46
IQ - Iraq 42
PK - Pakistan 39
ZA - Sudafrica 39
ES - Italia 36
UZ - Uzbekistan 34
TR - Turchia 33
IR - Iran 32
AT - Austria 31
CH - Svizzera 31
EC - Ecuador 31
BE - Belgio 24
CO - Colombia 20
VE - Venezuela 20
BJ - Benin 19
CL - Cile 19
CZ - Repubblica Ceca 18
PY - Paraguay 18
TN - Tunisia 18
AE - Emirati Arabi Uniti 15
MA - Marocco 15
GR - Grecia 14
KE - Kenya 14
LB - Libano 13
SA - Arabia Saudita 12
DZ - Algeria 11
EG - Egitto 11
JM - Giamaica 11
JO - Giordania 10
NP - Nepal 10
AL - Albania 9
BG - Bulgaria 9
EU - Europa 9
MY - Malesia 9
LT - Lituania 8
PH - Filippine 8
AU - Australia 7
AZ - Azerbaigian 6
IL - Israele 6
KZ - Kazakistan 6
OM - Oman 6
BO - Bolivia 5
GE - Georgia 5
NI - Nicaragua 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
HR - Croazia 4
KG - Kirghizistan 4
PE - Perù 4
UY - Uruguay 4
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
HN - Honduras 3
QA - Qatar 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
CG - Congo 2
GA - Gabon 2
GT - Guatemala 2
KW - Kuwait 2
LC - Santa Lucia 2
MD - Moldavia 2
ME - Montenegro 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
TT - Trinidad e Tobago 2
Totale 28.781
Città #
Singapore 2.052
Dallas 1.929
Santa Clara 1.373
Chandler 1.318
Dublin 978
Moscow 847
Jacksonville 842
San Jose 708
Houston 691
Ashburn 614
Boardman 428
Chicago 394
Abidjan 391
Hefei 352
Los Angeles 343
Catania 315
Nanjing 273
Lawrence 270
Cambridge 269
Lauterbourg 269
Beijing 246
Andover 243
Seoul 207
Ho Chi Minh City 200
Toronto 193
Council Bluffs 171
Munich 171
New York 167
Des Moines 147
Hanoi 123
Civitanova Marche 114
Helsinki 106
Wilmington 102
Kochi 99
San Mateo 99
Abuja 98
The Dalles 92
São Paulo 90
Dakar 87
Buffalo 85
Columbus 85
Nanchang 81
Rome 81
Lappeenranta 65
Hebei 59
Lagos 59
Shenyang 59
Hong Kong 52
Saint Petersburg 52
Dong Ket 50
Bremen 49
Warsaw 49
Changsha 47
Jiaxing 47
Ottawa 47
Palermo 47
Parma 47
Modica 45
Rio de Janeiro 44
Orem 43
Grafing 41
Tokyo 40
Tianjin 39
Brooklyn 38
Montreal 37
Amsterdam 34
Da Nang 34
Falls Church 32
Milan 32
Atlanta 30
London 30
Denver 28
Phoenix 28
Boston 27
Stockholm 27
Belo Horizonte 26
Chennai 26
Poplar 23
Brussels 22
Johannesburg 22
Port Harcourt 22
Seattle 22
Tehran 22
Manchester 21
Mumbai 21
Haiphong 20
San Francisco 20
Cotonou 19
Guarulhos 18
Norwalk 18
Porto Alegre 18
Augusta 16
Baghdad 16
Fortaleza 16
Jakarta 16
Mexico City 16
San Giovanni la Punta 16
Curitiba 15
Goiânia 15
Ningbo 15
Totale 19.582
Nome #
Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy 429
"Diagnosis on the Dock" project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model 334
Acute non A-E hepatitis in eastern Sicily: the natural History and the role of hepatitis G virus 248
Lack of clinical and histological progression of chronic hepatitis C in individuals with true persistently normal ALT: the result of a 17-year follow-up 223
A human case of Hymenolepis diminuta in a child from eastern Sicily 198
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 190
Biological and clinical markers in colorectal cancer: state of the art 189
Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review 181
A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole 173
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 168
Drop in CD4+ counts below 200 cells/µL after reaching (or starting from) values higher than 350 cells/µL in HIV‐infected patients with virological suppression 165
A measles outbreak in Catania, Sicily: the importance of high vaccination coverage and early notification of cases for health and economic reasons 164
Ceftazidime-Avibactam Treatment for Klebsiella pneumoniae Bacteremia in Preterm Infants in NICU: A Clinical Experience 163
Adenosine-induced bronchoconstriction: comparison between nedocromil sodium and sodium cromoglycate 163
Retrospective survey on laparoscopic cholecystectomy in the cirrhotic patient 159
Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease 159
Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review 158
Bronchodilator effect of Aerochamber and Inspirease in comparison with metered dose inhaler 154
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 154
Clinical characteristics and predictors of death among hospitalized patients infected with SARS‑CoV‑2 in Sicily, Italy: A retrospective observational study 154
[In Process Citation] 153
Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations 151
Bone disease in the setting of HIV infection: update and review of the literature 150
Achromobacter xylosoxidans meningitis in an immunosuppressed patient 149
Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations 144
Bioclinical markers in breast cancer: updates and perspectives 144
Long-Term Survivors in a Cohort of People Living with HIV Diagnosed between 1985 and 1994: Predictive Factors Associated with More than 25 Years of Survival 143
Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). 141
Hepatocellular carcinoma in HIV positive patients 140
Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion 138
Anal cancer in people living with HIV: the Iimportance of the screening and of early diagnosis 138
Clinical and biological markers in gastric cancer: update and perspectives 136
Cancer screening in HIV-infected patients: early diagnosis in a high-risk population 135
Containment effort reduction and regrowth patterns of the Covid-19 spreading 135
Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management 134
Efficacia sinergica dell’associazione albendazolo-metronidazolo nella giardiasi refrattaria a monoterapia con metronidazolo 132
Atypical Presentation of PKDL due to Leishmania infantum in an HIV-Infected Patient with Relapsing Visceral Leishmaniasis 131
Acoustic Radial Force Impulse as an effective tool for a prompt and reliable diagnosis of hepatocellular carcinoma - preliminary data 131
Bacterial and Fungal Co-Infections and Superinfections in a Cohort of COVID-19 Patients: Real-Life Data from an Italian Third Level Hospital 131
Fatal hepatitis during Epstein-Barr virus reactivation 130
Cervical cancer in women living with HIV: a review of the literature 130
Interferon-γ and Interleukin-17 production from PPD-stimulated PBMCss of patients with pulmonary tuberculosis 128
Antiretroviral therapy in geriatric HIV patients: The GEPPO cohort study 128
Mucorales/Fusarium Mixed Infection in Hematologic Patient with COVID-19 Complications: An Unfortunate Combination 127
Clinical, virological and epidemiological aspects of acute B hepatitis in the Catania area (Italy). 127
HIV-associated psoriasis: Epidemiology, pathogenesis, and management. 126
Post-infectious ST elevation myocardial infarction following a COVID-19 infection: A case report 126
Epatite acuta B nella provincia di Catania: valutazione epidemiologica, clinica e virologica nel decennio 1997-2007 124
Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations 123
Manifestazioni cliniche e modificazioni sierologiche a lungo termine dopo infezione da Mycoplasma pneumoniae 123
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 123
A new sampling method for spleen stiffness measurement based on quantitative acoustic radiation force impulse elastography for noninvasive assessment of esophageal varices in newly diagnosed HCV-related cirrhosis 123
Could we consider the intima-media thickness (c-IMT)> 1 mm as a risk factor for cardiovascular diseases in HIV plus subjects chronically treated with antiretrovirals? 123
Urea/Creatinine Ratio’s Correlation with Creatine Kinase Normalization in Pediatric COVID-19 Patients with Myositis: Evaluating Prognostic and Predictive Value 122
Severe Neutropenia after Sarilumab Administration in Two COVID-19 Patients: Case Reports and Literature Review 122
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas 122
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 121
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 120
Acute hepatitis E in Catania (eastern Sicily) 1980-1994. The role of hepatitis E virus 120
Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review 120
Ribavirin up-regulates IL12 p40 gene expression and restores IL12 levels in Leishmania-treated PBMCs 119
HIV RNA suppression and immune restoration: can we do better? 119
Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis 119
Association between raised IL-8 serum levels and resistance to combined peg-interferon plus ribavirin therapy in HCV+ active chronic hepatitis 119
Baseline CD4/CD8 T-cell Ratio Predicts Prompt Immune Restoration upon cART Initiation 118
Anal cancer: Focus on HIV-positive patients in the HAART-era 117
Acute asthma in children: treatment in emergency 116
HIV Infection Diagnosis in a Late Presenter Patient during a Severe Imported Falciparum Malaria: A Challenging 116
Epidemiological and clinical characteristics of nontuberculous mycobacterial infections: A retrospective female cohort study in an Italian population 115
Effects of ribavirin on interleukin-12 expression by peripheral blood mononuclear cells isolated from HIV and HIV-leishmania patients 115
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 115
Legionella pneumophila pneumonia: A 5-year retrospective clinical evaluation and commentary 114
Is it safe and cost saving to defer the CD4+ cell count monitoring in stable patients on ART with more than 350 or 500 cells/µL? 114
Long-term survivors in a cohort of HIV+ patients diagnosed between 1985 and 1992: predictive factors associated with more than 25 years of survival 114
Antibiotic Therapy Duration for Multidrug-Resistant Gram-Negative Bacterial Infections: An Evidence-Based Review 114
Mucosal leishmaniasis: an underestimated presentation of a neglected disease 113
Isolated laryngeal leishmaniasis in a 55-year-old man with dysphonia and rheumatoid arthritis: Case report and literature review 113
The role of micronutrients in the diet of HIV-1-infected individuals 112
Influence of hepatitis G virus coinfection on the clinical course of chronic hepatitis C 112
Rare case of Rhodococcus hoagii bacteremia in an HIV late‑presenter with NTM pulmonary disease: A case report and review of the literature 111
Changes in serum Interleukin-33 concentration before and after treatment with pegylated interferon alfa-2a plus ribavirin in patients with chronic hepatitis C genotype 1b infection 111
Methicillin‑sensitive Staphylococcus aureus prosthetic vascular graft infection after a Fontan procedure in an adult patient: A case report 111
Non-AIDS defining cancers: a comprehensive update on diagnosis and management 111
The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C 109
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 109
Vitamin D3: an ever green molecule 108
Effect of an aerosol delivery system on bronchodilator activity 108
Oral fosfomycin formulation for acute bacterial prostatitis; a new role for an old molecule: A case report and brief literature review 107
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 107
Entecavir resistance in a patient with treatment‑naïve HBV: A case report 107
HIV AND COLORECTAL CANCER. NEW INSIGHTS AND REVIEW OF THE LITERATURE 107
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96-week retrospective study 106
Circulating fibrocytes as a marker of liver fibrosis in chronic hepatitis C 106
Intravenous Fosfomycin: A Potential Good Partner for Cefiderocol. Clinical Experience and Considerations 106
Anal cancer in HIV-positive patients 105
HCV and HBV infection among multitransfused thalassemics from eastern Sicily 105
Quantitative evaluation of interleukin-12 p40 gene expression in peripheral blood mononuclear cells 105
Preliminary investigation on intrafamilial spread of hepatitis C virus (HCV) 105
Eosinophilic ileocolitis by Enterobius vermicularis: a descrition of two rare cases 105
CCR5 and CCR3 expression on T CD3+ lymphocytes from HIV/Leishmania co-infected subjects 104
Totale 13.637
Categoria #
all - tutte 94.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021425 0 0 0 0 0 0 0 0 0 69 258 98
2021/20221.940 195 295 22 30 302 30 274 69 162 18 85 458
2022/20233.622 300 178 82 390 377 614 11 574 865 31 124 76
2023/20241.470 91 193 72 94 74 302 39 103 6 75 262 159
2024/20256.316 67 843 354 351 1.334 682 228 358 461 592 637 409
2025/202612.011 738 772 2.267 947 2.054 2.298 1.487 284 532 632 0 0
Totale 29.425